Tag: CoV-2

Understanding the effect of these variations on the immune response can give some clarity about the efficacy of vaccination against the variants of SARS COV-2

With triple antigen targeting, the vaccine is claimed to offer better protection against COVID-19 variants. While Oravax Medical Inc has been established to accelerate the vaccine’s path to market, clinical trials are expected to commence in Q2 2021......................

Partners aim to provide potent neutralizing antibodies for COVID-19 pandemic response. The approach is complementary to future COVID-19 vaccines.........................

Over a hundred healthcare professionals have joined hands with the Federation of Indian Animal Protection Organisations (FIAPO) under the “Doctors for One Health” initiative to address the rapidly growing challenges for healthcare systems.......................

Remarked Minister of Science and Technology, Dr Harsh Vardhan while releasing a compendium of more than 100 technologies, 93 industry partners listed and with over 60 of these technologies having been transferred to the industry by CSIR....................

Human trials of India’s first indigenous experimental vaccine against COVID-19, COVAXIN, developed by Bharat Biotech is set to begin across India in July........................

Syngene has indigenously developed an anti-COV-2 IgG ELISA (Enzyme-Linked Immunosorbent Assay) at its research facility in Bengaluru. Having partnered with Hi-Media, the commercialized kit will be launched under the brand name ELISafe 19...............

CSIR through its NMITLI program approves a multi institutional project to develop human monoclonal antibodies (hmAbs) that can neutralize SARS-CoV-2 in patients. The project will be implemented by National Centre for Cell Science (NCCS), IIT-Indore and PredOmix Technologies with Bharat Biotech International, as the commercialization partner...........................

A new study by Indian Institute of Technology (IIT), Jodhpur has highlighted that loss of smell and taste of infected patients makes their entire Central Nervous System (CNS) and the underlying structures in the brain more prone to viral infection with devastating effects.................

CSIR-Institute of Microbial Technology (IMTECH) will carry out genome sequencing of coronavirus SARS-Cov-2 to understand its evolution and mutation pattern.................